AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Immix Biopharma, Inc. Director's Dealing 2021

Dec 16, 2021

34423_dirs_2021-12-15_fe20e052-e910-4dcb-a949-0a8337a245c5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immix Biopharma, Inc. (IMMX)
CIK: 0001873835
Period of Report: 2021-12-15

Reporting Person: Torchilin Vladimir P (Scientific Co-Founder)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	900000	Direct